removed once rhythm was established with the bipolar electrode. This anaesthetic had been complicated by postoperative hallucinations. The technique used was no premedication and a thiopentone induction with isoflurane in nitrous oxide and oxygen maintenance.
Induction of anaesthesia for the August repositioning of electrode consisted of no premedication and a vital capacity breath inhalation of 4% halothane in oxygen. 5 Loss of eyelash reflex was achieved in 15 seconds. Muscle relaxation for tracheal intubation was attained with vecuronium 6 mg and maintenance was with nitrous oxide 70%, oxygen 30% and halothane 0.5%. Intra-operative monitoring consisted of ECG, automatic noninvasive blood pressure, capnography and pulse oximetry. At induction heart rate was a paced rhythm of 70 beats/m in and arterial blood pressure was 115/70 mmHg. To enable transcutaneous pacing, two adhesive patch electrodes (Quik-Pace, Physio-Control Corporation) were applied prior to commencement of surgery, one each to the anterior and posterior chest wall. Following induction of anaesthesia, ability to perform transcutaneous cardiac pacing was ensured prior to manipulation of the permanent pacemaker electrode.
Upon disconnection of the malpositioned electrode, the underlying cardiac rhythm on electrocardiography was asystole. Transcutaneous pacing was commenced with a Lifepak 10 portable defibrillator with a pacing module (Physio-Control Corportion, Redmond, Wa., U,S.A.). This was necessary as there was no cardiac output evident upon disconnection of the electrode, unlike the previous procedure when cardiac output was maintained by the unipolar electrode. A current output of 60 mA and a rate of 8 5 beats/m in resulted in systolic blood pressure recordings in the range of 95-110 mmHg.
Repositioning of the pacemaker electrode was accomplished in 10 minutes and the trans- cutaneous pacing was discontinued. The surgical team expressed satisfaction with the operating conditions and stated that the minor movement associated with the external pacing and did not impede the procedure.
The patient left the operating theatre 45 minutes after induction of anaesthesia in a stable paced rhythm. There was a rapid smooth emergence, free from hallucinations and the patient was discharged home two days later. DISCUSSION Noninvasive, transcutaneous cardiac pacing was first described in 1952. 6 Since that time it has become an established therapy in the treatment of bradyarrhythmias in cardiac units and emergency departments. There have been surprisingly few reports of the use of external cardiac pacing in the anaesthetic literature and little evaluation of transcutaneous cardiac pacing under anaesthetic conditions. Berliner and others 4 studied transcutaneous pacing in twenty-one patients with normal cardiac rhythm under general anaesthesia. However, there are few descriptions of the therapeutic use of transcutaneous cardiac pacing despite its demonstrated efficacy, safety and ease of use. 3 Haemodynamic stability with transcutaneous pacing has been reported as equivalent to right ventricular endocardial pacing. 7 The adhesive contact pads are simple and easy to apply and the complications of central venous access that may be associated with temporary transvenous cardiac pacing are avoided. In this patient, the potential complications of invasive temporary transvenous pacing (and thus another procedure) were confidently avoided by ensuring that the transcutaneous pacing was effective prior to surgical manipulation of the permanent pacemaker.
Arrhythmia management is a necessary skill for anaesthetic staff. Cardiac arrhythmias may be seen during anaesthesia in patients with electrolyte imbalance, pre-existing cardiac disease (ischaemic or otherwise), hypoxia, hypercapnia or due to pharmacologic interventions. Pacemaker failure associated with anaesthesia has been reported with diathermy reprogramming,S positive pressure ventilation, right ventricular perforation, nitrous oxide entrapment in permanent pacemaker generator pocket 9 and simply pulse generator failure.
Placement of temporary transvenous pacemakers is a procedure not commonly Anaesthesia and Jntensi~'e Care. Vol. 20. No. 4. Nm'ember, 1992 performed by anaesthetists and noninvasive transcutaneous cardiac pacing is a viable alternative. The equipment for noninvasive transcutaneous pacing can be found in the cardiac or emergency departments of most major hospitals. The recommended indications for its use include complete heart block, other bradyarrhythmias, unexpected permanent pacemaker failure and unknown underlying rhythm.
In this patient rapid induction with a vital capacity breath of 4% halothane in oxygen was associated with cardiovascular stability and resulted in prompt, lucid emergence as described by Ruffie and others. S In contrast to the previous thiopentone and isoflurane anaesthetic, there were no hallucinations.
It is recommended that anaesthetic staff familiarise themselves with the equipment and technique of non invasive transcutaneous pacing to facilitate rapid and flexible management of bradyarrhythmias in the operating suite. Safety, ease of use and efficacy have all been demonstrated with transcutaneous pacing. While not replacing conventional arrhythmia therapies, this simple technique should be considered in the management of expected and unexpected bradyarrhythmias.
